Related Experiment Video
Updated: Apr 1, 2026

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
Published on: March 6, 2019
Systematic Evaluation of Maleimide Spacer Impact on Drug-Linker Deconjugation in Antibody-Drug Conjugates Ex Vivo and
Andrea Hernández Rojas1, Jodi Wong1, Diego A Alonzo1
1Zymeworks Inc., 114 East 4th Avenue, Suite 800, Vancouver, BC V5T 1G4, Canada.
Abstract:
Antibody-drug conjugates (ADCs) are an important class of targeted therapeutics that require comprehensive stability characterization with robust analytical methods for their proper design and development. To date, most ADCs in the clinic or in preclinical development possess some degree of instability; in the case of thiol-maleimide ADCs, drug-linker deconjugation can happen through the retro-Michael reaction; simultaneously, maleimide hydrolysis can prevent further deconjugation, as the ring-opened derivative is more resistant to elimination. Here, we describe the development of a novel generic immunocapture method to recover ADCs from complex biological matrices prior to characterization by reverse-phase liquid chromatography-mass spectrometry (RPLC-MS), focusing primarily on deconjugation and succinimide ring-opening quantification. Employing this method, we systematically evaluated 22 thiol-maleimide ADCs in ex vivo and in vivo settings across rat, mouse, and monkey sera, with ADCs featuring either maleimidocaproyl (MC) or maleimido-triethylene glycol (MT) spacer units, with diversity in antibody, drug loading, cleavable linker, and payload composition, including clinically validated drug-linkers such as MC-GGFG-DXd and MC-VCit-MMAE. We observed that ADCs bearing a hydrophilic MT spacer achieved higher levels of ring-opening and thioether adduct stabilization, which led to lower levels of deconjugation compared to hydrophobic MC spacer ADCs, which showed moderate ring-opening and substantial deconjugation in vivo. These trends were generally observed regardless of antibody backbone and remaining drug-linker structure, reflecting the influence of spacer structure on water accessibility to the maleimide ring. Our immunoprecipitation-LC-MS results were compared to orthogonal total antibody (Tab) and ADC (conjugated antibody) ELISA pharmacokinetic (PK) profiles. While deconjugation profiles were generally consistent across methods, IP-MS provided more quantitative measurements and was more sensitive to subtle differences in deconjugation. Our findings shed light on the importance of the spacer structure on thiol-maleimide ADC stability.
More Related Videos
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018